期刊文献+

β肌球蛋白重链及心脏型肌球蛋白结合蛋白C基因突变的肥厚型心肌病患者生存分析 被引量:5

Survival rate of patients with hypertrophiccardiomyopathy due to gene mutations of β myosin heavy chain and MYBPC3
暂未订购
导出
摘要 目的探讨携带β肌球蛋白重链(MYH7)及心脏型肌球蛋白结合蛋白C(MYBPC3)基因突变的肥厚型心肌病患者的6年生存情况。方法对采用测序方法确定的携带MYH7及MYBPC3基因突变的70例肥厚型心肌病患者进行前瞻性的随访。结果平均随访时间为(5.8±1.8)年,期间共有14例患者死亡,其中MYH7突变患者10例(32.1%/1000人年,95%CI为12.5~51.5),MYBPC3突变患者4例(35.2%/1000人年,95%CI为13.9~68.9),两者比较差异无统计学意义(P>0.05)。7例携带MYH7突变的患者发生猝死,基因突变的部位均位于MYH7基因的头部;而携带MYBPC3突变的患者均未发生猝死,两者比较差异有统计学意义(P<0.01)。结论携带MYH7基因突变的肥厚型心肌病患者发病年龄和死亡年龄均较早,猝死发生率高。携带位于MYH7基因头部突变的肥厚型心肌病患者较杆部突变患者的左心室最大室壁厚度更厚,猝死发生率高,更容易发生心力衰竭。对肥厚型心肌病患者进行基因检查十分必要。 Objective To investigate the 6-year survival rate of patients with hypertrophiccardio- myopathy(HCM) due to gene mutations of β myosin heavy chain(MYH7) and cardiac myosin binding protein C(MYBPC3). Methods Gene mutations of MYH7 and MYBPC3 in 70 HCM patients were identified by sequencing during the prospective follow-up. Results The mean followup time was 5.8±1.8 years during which 14 patients died,of them,0 had MYH7 mutations and 4 had MYBPC3 mutations(P〉0.05). Sudden death occurred in 7 patients with MYH7 mutations in the head while no sudden death occurred in those with MYBPC3 mutations(P〈0.01). Conclusion MYH7 mutations and death occur in younger HCM patients with MYH7 mutations whose sudden death rate is high. The ventricular wall is thicker in HCM patients with MYH7 mutations in the head than in those with MYH7 mutations in the stem,which is easy to lead to heart failure. It is,thus,necessary to detect gene mutations in HCM patients.
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2012年第4期355-357,共3页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
基金 国家自然科学基金(81100160)
关键词 肌球蛋白重链 心肌肌球蛋白 心肌病 肥厚性 基因型 突变 myosin heavy chains cardiac myosins cardiomyopathy, hypertrophic genotype mutation
  • 相关文献

参考文献10

  • 1Maron BJ,McKenna WJ,Danielson GK. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy:A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and tbe European Society of Cardiology Committee for Practice Guidelines[J].Journal of the American College of Cardiology,2003.1687-1713.
  • 2Gersh BJ,Maron BJ,Bonow RO. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J].Journal of Thoracic and Cardiovascular Surgery,2011.1303-1338.
  • 3Maron BJ,Lindberg J,Haas TS. Speckled ventricular septum in hypertrophic cardiomyopathy revisited after 30 years[J].American Journal of Cardiology,2011.1862-1863.
  • 4Zou Y,Song L,Wang Z. Prevalence of idiopathic hypertrophic cardiomyopathy in China:A population based echocardiographic analysis of 8080 adults[J].American Journal of Medicine,2004.14-18.
  • 5Maron BJ. Hypertrophic cardiomyopathy:A systematic review[J].Journal of the American Medical Association,2002.1308-1320.doi:10.1001/jama.287.10.1308.
  • 6Gautel M,Zrffardi O,Freiburg A. Phosphorylation switches specific for the cardiac isoform of myosin binding protein C:A modulator of cardiac contraction[J].EMBO Journal,1995.1952-1960.
  • 7Bonne G,Carrier L,Bercovici J. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy[J].Nature (Genet,1995.438-440.
  • 8Ackerman MJ,VanDriest SL,Ommen SR. Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy:A comprehensive outpatient perspective[J].Journal of the American College of Cardiology,2002.2042-2048.
  • 9Song L,Zou Y,Wang J. Mutations profile in Chinese patients with hypertrophic cardiomyopathy[J].Clinica Chimica Acta,2005.209-216.
  • 10Liu SX,Hu SJ,Sun J. Characteristics of the beta myosin heavy chain gene Ala26Val mutation in a Chinese family with hypertrophic cardiomyopathy[J].European Journal of Internal Medicine,2005.328-333.

同被引文献65

  • 1王曙霞,邹玉宝,傅春燕,王继征,宋雷,张伟丽,惠汝太.心脏型肌钙蛋白Ⅰ基因4693 C/T突变导致家族性心尖部肥厚型心肌病[J].中国分子心脏病学杂志,2006,6(5):253-256. 被引量:7
  • 2刘文玲,谢文丽,胡大一,朱天刚,李运田,孙艺红,李翠兰,李蕾,李田昌,边红,仝其广,杨松娜,范瑞云,崔炜.十个汉族家族性肥厚型心肌病MYH7、MYBPC3和TNNT2基因筛查结果及相应的临床特征[J].中华心血管病杂志,2006,34(3):202-207. 被引量:25
  • 3陶琴,杨俊华,郑冬冬,董宁征,杨向军,宋建平,蒋廷波,李红霞,韩莲花,周炳元,赵彩明,蒋文平.汉族家族性肥厚型心肌病人群MYH7基因Val606Met突变分析[J].中华心血管病杂志,2007,35(11):992-995. 被引量:2
  • 4Yue ZC, Zhang YH, Xie J, et al. Transient receptor po- tential (TRP) channels and cardiac fibrosis [ J]. Current Topics Med Chem, 2013, 13 : 270-282.
  • 5Banerjee I, Fuseler JW, Price RL, et al. Determination of cell types and numbers during cardiac development in theneonatal and adult rat and mouse [ J ]. Am J Physiol Heart Circ Physiol, 2007, 293:H1 883-891.
  • 6Zeisberg EM, Kalluri R. Origins of cardiac fibroblasts[ J]. Circ Res, 2010, 107(11) : 1 304-312.
  • 7Turner NA. The cardiac fibroblast [ M ]. Kerala: Research Signpost, 2011.
  • 8Camelliti P, Green CR, LeGrice I , et al. Fibroblast net- work in rabbit sinoatrial node: structural and functional i- dentification of homogeneous and heterogeneous cell cou- pling[J]. Circ Res, 2004, 94(6) : 828-835.
  • 9Souders CA, Bowers SL, Baudino TA. Cardiac fibroblast: the renaissance cell [ J ]. Circ Res, 2009, 105: 1 164-176.
  • 10Camelliti P, Borg TK, Kohl P. Structural and functional characterisation of cardiac fibroblasts [ J ]. Cardiovasc Res, 2005, 65(1) : 40-51.

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部